APA (7th ed.) Citation

Liu, M., Xu, X., Peng, K., Hou, P., Yuan, Y., Li, S., . . . Liu, T. (2022). Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway. Oncogenesis, 11(1), 1. https://doi.org/10.1038/s41389-022-00428-0

Chicago Style (17th ed.) Citation

Liu, Mengling, et al. "Heparanase Modulates the Prognosis and Development of BRAF V600E-mutant Colorectal Cancer by Regulating AKT/p27Kip1/Cyclin E2 Pathway." Oncogenesis 11, no. 1 (2022): 1. https://doi.org/10.1038/s41389-022-00428-0.

MLA (9th ed.) Citation

Liu, Mengling, et al. "Heparanase Modulates the Prognosis and Development of BRAF V600E-mutant Colorectal Cancer by Regulating AKT/p27Kip1/Cyclin E2 Pathway." Oncogenesis, vol. 11, no. 1, 2022, p. 1, https://doi.org/10.1038/s41389-022-00428-0.